Effect of high-dose methyl-prednisolone on brainstem encephalopathy and basal ganglia impairment complicating cat scratch disease

被引:8
|
作者
Genizi, Jacob
Kasis, Imad
Schif, Aharon
Shahar, Eli [1 ]
机构
[1] Meyer Children Hosp, Rambon Med Ctr, Child Neurol Unit, Haifa, Israel
[2] Meyer Children Hosp, Rambon Med Ctr, Epilepsy Serv, Haifa, Israel
[3] Meter Children Hosp, Rambam Med Ctr, Rappaport Sch Med, Infect Dis Serv, Haifa, Israel
来源
BRAIN & DEVELOPMENT | 2007年 / 29卷 / 06期
关键词
cat scratch disease; encephalopathy; brainstem; basal ganglia;
D O I
10.1016/j.braindev.2006.11.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cat scratch disease (CSD) is a zoonotic illness caused by the Gram negative bacillus Bartonella henselae characterized by a small skin lesion at the site of a bite, lick or scratch by a cat, commonly followed by regional lymphadenopathy 1 or 2 weeks later. We report herein on severe neurological complications of CSD combining brainstem encephalopathy and basal ganglia impairment. This 12-year-old female acutely presented to a local hospital with profound coma and a prolonged tonic posturing of extremities. On the neurological examination she was deeply comatose with pin-point pupils and lack of vestibulo-ocular responses, suggestive of brainstem encephalopathy, along with marked rigid hypertonicity suggestive also of basal ganglia impairment. Initially suspecting Herpes simplex encephalitis or acute disseminated encephalomyelitis she was promptly started with high-dose methyl-prednisolone and acyclovir. Her parents apparently reported that she was scratched by a kitten some 4 weeks prior to her present admission and as such, suspecting CSD, she was begun with doxycycline and rifampicin. Her serology had proven positive for IgM antibodies to Bartonella, henselae establishing the diagnosis. She regained consciousness after 4 days and the signs of brainstem and extra-pyramidal impairment also gradually abated and disappeared after 10 days. A follow-up exam after a month disclosed mild extra-pyramidal abnormalities which disappeared after 3 months. Although extremely rare, CSD should be also considered in a patient presenting with a severe encephalopathy and associated basal ganglia impairment. The prompt administration of high-dose methyl-prednisolone upon admission may have contributed to the favorable outcome in our patient and therefore should be advocated in any patient presenting with profound encephalopathy regardless the underlying etiology recovered later. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:377 / 379
页数:3
相关论文
共 12 条
  • [1] RESPONSIVENESS TO HIGH-DOSE IV METHYL-PREDNISOLONE OF UNCONTROLLED ASTHMATICS
    CHANEZ, P
    PARADIS, L
    DESROCHES, A
    PERONNARD, C
    PAGANIN, F
    GODARD, P
    BOUSQUET, J
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 311 - 311
  • [2] HIGH-DOSE INTRAVENOUS METHYL-PREDNISOLONE IN CHRONIC POLYMYOSITIS DERMATOMYOSITIS
    CASTROGAGO, M
    ALVEZGONZALEZ, F
    PENAGUITIAN, J
    [J]. BRAIN & DEVELOPMENT, 1986, 8 (05): : 570 - 570
  • [3] Possible role of high-dose corticosteroids in the treatment of cat-scratch disease encephalopathy
    Weston, KD
    Tran, T
    Kimmel, KN
    Maria, BL
    [J]. JOURNAL OF CHILD NEUROLOGY, 2001, 16 (10) : 762 - 763
  • [4] HIGH-DOSE INTRAVENOUS METHYL-PREDNISOLONE IN CHRONIC RELAPSING DYSIMMUNE POLYNEUROPATHY (CRDP)
    CASTROGAGO, M
    RODRIGUEZNUNEZ, A
    [J]. BRAIN & DEVELOPMENT, 1989, 11 (05): : 347 - 347
  • [5] Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse
    Acar, Memed
    Gedizlioglu, Muhtesem
    Koskderelioglu, Asli
    Ozturk, Feriste
    Kilinc, Serkan
    Talay, Nurdan
    [J]. EUROPEAN NEUROLOGY, 2012, 68 (01) : 20 - 22
  • [6] HIGH-DOSE INTRAVENOUS METHYL-PREDNISOLONE PULSE THERAPY IN TREATMENT OF ACTIVE RHEUMATOID-ARTHRITIS
    BACHMANN, F
    GENTH, E
    [J]. MEDIZINISCHE WELT, 1985, 36 (11): : 304 - 308
  • [7] HIGH-DOSE INTRAVENOUS METHYL PREDNISOLONE (PULSE THERAPY) IN THE TREATMENT OF RHEUMATOID DISEASE
    WILLIAMS, IA
    BAYLIS, EM
    ENGLISH, J
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1981, 10 (02) : 153 - 155
  • [8] HIGH-DOSE METHYL PREDNISOLONE THERAPY IN ESTABLISHED ACUTE GRAFT VERSUS HOST-DISEASE
    PRENTICE, HG
    BATEMAN, SM
    BRADSTOCK, KF
    HOFFBRAND, AV
    [J]. BLUT, 1980, 41 (03): : 175 - 177
  • [9] HIGH-DOSE METHYL PREDNISOLONE (HDMP) TREATMENT FOR ACUTE GRAFT VERSUS HOST-DISEASE (GVHD)
    KANOJIA, M
    ZANDER, A
    VELLEKOOP, L
    MINNHAAR, G
    SPITZER, G
    VERMA, D
    DICKE, K
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 159 - 159
  • [10] HIGH-DOSE METHYL PREDNISOLONE (HDMP) AS PROPHYLAXIS AND TREATMENT FOR ACUTE GRAFT VERSUS HOST-DISEASE (GVHD)
    KANOJIA, M
    ZANDER, A
    VELLEKOOP, L
    CULBERT, S
    MINNHAAR, G
    SPITZER, G
    VERMA, D
    DICKE, K
    [J]. EXPERIMENTAL HEMATOLOGY, 1982, 10 : 33 - 33